Profile of cerebrospinal fluid and serum cytokines in patients with relapsing-remitting multiple sclerosis: A correlation with clinical activity

Immunopharmacology and Immunotoxicology

Volumn 20, Issue 3, 1998, Pages 373-382

  Carrieri, P B ^a   Provitera, V ^a   De Rosa, T ^a   Tartaglia, G ^a   Gorga, F ^a   Perrella, O ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b AO Dei Colli Hospital for Infectious Diseases D Cotugno   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CYTOKINE; GLUCOSE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G; INTERLEUKIN 10; PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SERUM;

EID: 0031689911     PISSN: 08923973     EISSN: None     Source Type: Journal    
DOI: 10.3109/08923979809034820     Document Type: Article

References (25)

1. Hoffmann, F.M., Hinton, D.R., Johnson, K., and Merrill, J.E., Tumor necrosis factor identified in multiple sclerosis brain, J. Exp. Med., 170:607, 1989.
2. Rieckmann, P., Albrecht, M., Kitze, B., Weber, T., Tumani, H., Broocks, A., Luer, W., and Poser, S., Cytokine mRNA levels in mononuclear blood Cells from patients with multiple sclerosis, Neurology, 44:1523, 1994.
3. Cannella, B., and Raine, C.S., The adhesion molecule/cytokine profile of multiple sclerosis lesions, Ann. Neurol., 37:424, 1995.
4. Mosmann, T.R., Coffmann, R.L.J., Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties, Annu. Rev. Immunol. Immunol., 7:145, 1989.
5. Gallo, B., Piccinno, M.G., Krzalic, L., and Tavolato, B., Tumor necrosis factor alpha and neurological diseases. Failure in detecting TNF-alpha in the cerebrospinal fluid from patients with multiple sclerosis, AIDS dementia complex and brain tumor. J Neurimmunol, 23:41, 1989.
6. Perrella, O., Carrieri, P.B., De Mercato, R., and Buscaino, G.A., Markers of activated T lymphocytes and T cell receptor gamma/delta+ in patients with multiple sclerosis, Eur. Neurol., 33:152, 1993.
7. Peter, J.B., Boctor, F.N., and Tourtellotte, W.W., Serum and CSF levels of IL-2, sIL-2r, TNF-alpha and IL-1-beta in chronic progressive multiple sclerosis. Expected lack of clinical utility, Neurology, 41:121, 1991.
8. Shaw, C.E., Dunbar, P.R., Macaulay, H.A., and Neale, T.J., Measurement of immune markers in the serum and cerebrospinal fluid of multiple sclerosis patients during clinical remission, J. Neurol., 242:53, 1995.
9. Kittur, S.D., Kittur, D.S., Soncrant, T.T., Rapoport, S.I., Tourtellotte, W.W., Naegel, J.E, and Adler, W.H., Soluble interleukin-2 receptors in cerebrospinal fluid from individuals with various neurologicals disorders, Ann. Neurol., 28:168, 1990.
10. Sharief, M.K., and Thompson, E.J., In vivo relationship of tumor necrosis factor-alpha to blood brain barrier damage in patients with active multiple sclerosis, J. Neurimmunol., 38:27, 1992.
11. Carrieri, P.B., Maiorino, A., Provitera, V., Perrella, A., and Perrella, O., Evaluation of interleukin-10 and interferon-alpha in the cerebrospinal fluid and serum of patients with multiple sclerosis, Eur. J. Neurol., 3:544, 1996.
12. Salmaggi, A., Dufour, A., Eoli, M., Corsini, E., La Mantia, L., Massa, G., Nespolo, A., and Milanese, C., Low serum interleukin-10 levels in multiple sclerosis: further evidence for decreased systemic immunosuppression? J. Neurol., 243:13, 1996.
13. Carrieri, P.B., Provitera, V., Bruno, R., Perrella, M., Tartaglia, G., Busto, A. and Perrella, O., Possible role of transforming growth factor-b in relapsing-remitting multiple sclerosis, Neurological Research, 19:599, 1997.
14. Poser, C.M., Paty, D.W., Scheinberg, L., McDonald, W.I., Davis, F.A., Ebers, G.C., Johnson, K.P., Sibley, W.A., Silberberg, D.A. and Tourtellotte, W.W., New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol.. 13:227, 1983.
15. Link, H., and Tibbling, G., Principles of albumin and IgG analyses in neurological disorders: III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis, Scand. J. of Cl. and Lab. Invest. 37:397, 1977.
16. Keir, G., Luxton, R.W., and Thompson, E.J., Isoelectric focusing of cerebrospinal fluid immunoglobulin G: an annotated update, Ann. Clin. Biochem., 27:436,
17. Abbas, A.K., Murphy, H.M., and Sher, A., Functional diversity of helper T lymphocytes, Nature, 383:787, 1996.
18. Rott, O., Fleischer, B., and Cash, E., Interleukin-10 prevents experimental allergic encephalomyelitis in rats, Eur. J. Immunol., 24:1434, 1994.
19. Kennedy, M..K., Torrance, D.S., Picha, K.S., and Mohler, K.L., Analysis of cytokine m-RNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 m-RNA expression correlates with recovery, J. Immunol., 149:2496, 1992.
20. Olsson, T., Role of cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis, Eur. J. Neurol., 1:7, 1994.
21. Maffione, A.B., Nacci, C., Tatò, E., Satalino, R., Trojano, M., Ruggieri, M., Livrea, P., and Jirillo, E., In vivo effects of IFN-β administered in patients with relapsing-remitting multiple sclerosis. Pharmacol. Res. 35(supplement):72, 1997.
22. Jirillo, E., Pellegrino, N.M., and Antonaci, S., Role of Tumor necrosis factor α in physiological and pathological conditions. Med. Sci. Res. 23:75, 1995.
23. Oger, J.F., Roos, R., and Antel, J.P., Immunology of multiple sclerosis, Neurol. Clin., 1:655, 1983.
24. Fiorentino, D.F., Zlotnik, A., Mossmann, T.R., Howard, M. and O'Garra, A., IL-10 inhibits cytokine production by activated macrophages, J. Immunol., 147:3815, 1991.
25. Powrie, F., and Coffman R.L., Cytokine regulation of T cells function: potential for therapeutic intervention, Immunol. Today, 14:270, 1993.